(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: A Wingless β-Catenin Agonist That Increases Bone Formation Rate

被引：40

作者：

Pelletier, Jeffrey C. ^{[1
]}

Lundquist, Joseph T., IV ^{[1
]}

Gilbert, Adam M. ^{[4
]}

Alon, Nipa ^{[4
]}

Bex, Frederick J. ^{[2
]}

Bhat, Bheem M. ^{[2
]}

Bursavich, Mattew G. ^{[4
]}

Coleburn, Valerie E. ^{[2
]}

Felix, Luciana A. ^{[1
]}

Green, Daniel M. ^{[1
]}

Green, Paula ^{[2
]}

Hauze, Diane B. ^{[1
]}

Kharode, Yogendra P. ^{[2
]}

Lam, Ho-Sun ^{[2
]}

Lockhead, Susan R. ^{[3
]}

Magolda, Ronald L. ^{[1
]}

Matteo, Jeanne J. ^{[2
]}

Mehlmann, John F. ^{[1
]}

Milligan, Colleen ^{[2
]}

Murrills, Richard J. ^{[2
]}

Pirrello, Jennifer ^{[2
]}

Selim, Sally ^{[2
]}

Sharp, Michael C. ^{[2
]}

Unwalla, Ray J. ^{[1
]}

Vera, Matthew D. ^{[1
]}

Wrobel, Jay E. ^{[1
]}

Yaworsky, Paul ^{[2
]}

Bodine, Peter V. N. ^{[2
]}

机构：

[1] Wyeth Res, Chem Sci, Collegeville, PA 19426 USA

[2] Wyeth Res, Tissue Repair, Collegeville, PA 19426 USA

[3] Wyeth Res, Drug Safety & Metab, Collegeville, PA 19426 USA

[4] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 22期

关键词：

WNT; MUTATION; PATHWAY; OSTEOPOROSIS; INHIBITORS; PROTEINS;

D O I：

10.1021/jm9014197

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A high-throughput screening campaign to discover small molecule leads for the treatment of bone disorders concluded with the discovery of a compound with a 2-aminopyrimidine template that targeted the Wnt beta-catenin cellular messaging system. Hit-to-lead in vitro optimization for target activity and molecular properties led to the discovery of (1-(4-(naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine (5, WAY-262611). Compound 5 has excellent pharmacokinetic properties and showed a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration.

引用

页码：6962 / 6965

页数：4

共 50 条

[31] Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent
Zhumakova, Symbat
Tokusheva, Aliya
Zharkynbek, Tolganay
Balabekova, Marina
Koks, Sulev
Seilkhanov, Tulegen
Dembitsky, Valery
Zazybin, Alexey
Aydemir, Murat
Kemelbekov, Ulan
Kairanbayeva, Gulgul
Yu, Valentina
MOLECULES, 2024, 29 (21):
[32] Inhibition of EGFR Signaling by N-cyclohexyl-2-(1-(phenylsulfonyl)piperidin-4-yl) acetamide
Lin, Sensen
Li, Hang
Yu, Jun
Zhang, Luyong
Yan, Ming
Li, Hongyang
Li, Xinxin
Yuan, Shengtao
Sun, Li
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (11) : 1500 - 1507
[33] Synthesis, characterization and antimicrobial activity of some novel 4-(4-(arylamino)-6-(piperidin-1-yl)-1,3,5-triazine-2-ylamino)-N-(pyrimidin-2-yl)benzenesulfonamides
Desai, N. C.
Makwana, Atul H.
Senta, R. D.
JOURNAL OF SAUDI CHEMICAL SOCIETY, 2016, 20 (06) : 686 - 694
[34] 4-(Pyrimidin-2-yl)-1-thia-4-azaspiro[4.5]decan-3-one
Neuenfeldt, Patricia D.
Drawanz, Bruna B.
Cunico, Wilson
Tiekink, Edward R. T.
Wardell, James L.
Wardell, Solange M. S. V.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O3190 - U1450
[35] 1-(2-Chlorobenzoyl)-3-(pyrimidin-2-yl)thiourea
Rauf, M. Khawar
Yaseen, Samad
Ebihara, Masahiro
Badshah, Amin
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O84 - +
[36] Synthesis and Crystal Structure of 1-[4-(Pyrimidin-2-yl)piperazin-1-ylmethyl]-1H-benzotriazole
HE Feng-Qi WANG Bao-Lei LI Zheng-Ming ② SONG Hai-Bin (Elemento-organic Chemistry Institute
Chinese Journal of Structural Chemistry, 2006, (05) : 543 - 546
[37] Synthesis and crystal structure of 1-[4-(pyrimidin-2-yl)piperazin-1-ylmethyl]-1H-benzotriazole
He Feng-Qi
Wang Bao-Lei
Li Zheng-Ming
Song Hai-Bin
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2006, 25 (05) : 543 - 546
[38] Synthesis and Crystal Structure of 1-[4-(Pyrimidin-2-yl)piperazin-1-ylmethyl]-1H-benzotriazole
HE FengQi WANG BaoLei LI ZhengMing SONG HaiBin Elementoorganic Chemistry Institute State Key Laboratory of Elementoorganic Chemistry Nankai University Tianjin China
结构化学, 2006, (05) : 543 - 546
[39] Synthesis and crystal structure of [1-(toluene-4-sulfonyl)-piperidin-4-yl]-methanol
Girish, H. R.
Naveen, S.
Prasad, S. B. Benaka
Kumar, C. S. Ananda
Vinaya, K.
Sridhar, M. A.
Prasad, J. Shashidhara
Rangappa, K. S.
MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2008, 487 : 160 - 169
[40] 4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors
Rossi, Cristina
Fincham, Christopher I.
D'Andrea, Piero
Porcelloni, Marina
Ettorre, Alessandro
Mauro, Sandro
Bigioni, Mario
Binaschi, Monica
Maggi, Carlo A.
Nardelli, Federica
Parlani, Massimo
Fattori, Daniela
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6767 - 6769

← 1 2 3 4 5 →